Search

Your search keyword '"I Parker"' showing total 894 results

Search Constraints

Start Over You searched for: Author "I Parker" Remove constraint Author: "I Parker"
894 results on '"I Parker"'

Search Results

1. ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS)

2. E proteins control the development of NKγδT cells through their invariant T cell receptor

3. Zoop to poop: assessment of microparticle loads in gray whale zooplankton prey and fecal matter reveal high daily consumption rates

4. Stmol: A component for building interactive molecular visualizations within streamlit web-applications

5. Severe Acute Respiratory Syndrome–Associated Coronavirus 2 Infection and Organ Dysfunction in the ICU: Opportunities for Translational Research

6. Hemostatic Testing in Critically Ill Infants and Children

9. Chapter 15: Propulsion System

12. Plasma and Platelet Transfusion Strategies in Critically Ill Children With Malignancy, Acute Liver Failure and/or Liver Transplantation, or Sepsis: From the Transfusion and Anemia EXpertise Initiative–Control/Avoidance of Bleeding

13. Plasma and Platelet Transfusion Strategies in Critically Ill Children Following Noncardiac Surgery and Critically Ill Children Undergoing Invasive Procedures Outside the Operating Room: From the Transfusion and Anemia EXpertise Initiative–Control/Avoidance of Bleeding

15. Supplementary Data from Association of TP53 and CDKN2A Mutation Profile with Tumor Mutation Burden in Head and Neck Cancer

16. Data from Delineating the RAS Conformational Landscape

17. What Laboratory Tests and Physiologic Triggers Should Guide the Decision to Administer a Platelet or Plasma Transfusion in Critically Ill Children and What Product Attributes Are Optimal to Guide Specific Product Selection? From the Transfusion and Anemia EXpertise Initiative-Control/Avoidance of Bleeding

20. Anticoagulation in Extracorporeal Membrane Oxygenation: A Dilemma Wrapped in an Enigma*

21. Association of TP53 and CDKN2A mutation profile with tumor mutation burden (TMB) in head and neck cancer

22. CyBorD-DARA in Newly Diagnosed Transplant-Eligible Multiple Myeloma: Results from the 16-BCNI-001/CTRIAL-IE 16-02 Study Show High Rates of MRD Negativity at End of Treatment

23. Anatomical brain MRI study of pediatric cancer survivors treated with chemotherapy: Correlation with behavioral measures

24. Platelet Activation and Endothelial Cell Dysfunction

25. Comprehensive characterization of PTEN mutational profile in a series of 34,129 colorectal cancers

27. Quality of Life Analysis of a Phase II Randomized Controlled Trial Comparing 3D-Conformal Radiotherapy (3D-CRT) and Intensity Modulated Radiotherapy (IMRT) in Locally Advanced Rectal Cancer (TRI-LARC)

28. Acute Gastrointestinal Toxicity Results from a Multi-Institution, Phase 2, Randomized Controlled Trial Comparing 3D-Conformal Radiotherapy (3DCRT) Versus Intensity Modulated Radiotherapy (IMRT) for Locally-Advanced Rectal Cancer (TRI-LARC)

30. Coagulation Dysfunction Criteria in Critically Ill Children: The PODIUM Consensus Conference

31. Multiplexed identification of RAS paralog imbalance as a driver of lung cancer growth

32. Patterns of recurrence after prostate bed radiotherapy

33. CyBorD-DARA is potent initial induction for MM and enhances ADCP: initial results of the 16-BCNI-001/CTRIAL-IE 16-02 study

34. Structure of TFIIK for phosphorylation of CTD of RNA polymerase II

35. Severe Acute Respiratory Syndrome–Associated Coronavirus 2 Infection and Organ Dysfunction in the ICU: Opportunities for Translational Research

36. Catheter-Associated Deep Venous Thrombosis Prevention: Which Path to Choose?

38. Prevalence of diabetic and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities

39. Contributors

41. Neural correlates of working memory function in pediatric cancer survivors treated with chemotherapy: an fMRI study

42. Recommendations on RBC Transfusion Support in Children With Hematologic and Oncologic Diagnoses From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative

44. Proliferative signaling by ERBB proteins and RAF/MEK/ERK effectors in polycystic kidney disease

45. Hemostasis in Critical Illness: Better Tools, Better Answers!

46. Correlation of tumor mutational burden (TMB) with CDKN2A and TP53 mutation in HPV-negative head and neck squamous cell carcinoma (HNSCC)

47. Recommendations on Selection and Processing of RBC Components for Pediatric Patients From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative

48. Cancer and Sepsis

49. Sepsis

50. A Meta-analytic Review of Functional Communication Training Across Mode of Communication, Age, and Disability

Catalog

Books, media, physical & digital resources